Congratulations to the Clinical and Translational Science Award (CTSA) Pilot Study recipients. Raphael A. Clynes, MD, Pulmonary, Allergy & Critical Care, “Induction of Antitumor Immunity in Untreated CLL Patients Through the Use of Rituximab and Denileukin Diftitox (Ontak)” Daniel J. Kass, MD, Pulmonary, Allergy & Critical Care, "Targeting the MetAP2 Pathway in Pulmonary Arterial Hypertension" Gissette Reyes, MD, Preventive Medicine & Nutrition, “Lipoprotein Metabolism in Obese Postmenopausal Metabolically Healthy Obese versus Metabolically Abnormal Obese Women” Mishaela Rubin, MD, Endocrinology, “Osteocalcin and Glucose Homeostasis in Hypoparathyroidism” The pilot awards are part of the $54 million NIH grant Roadmap for Medical Research which aims to develop research models that will be characterized by multi-disciplinary teams who collaborate to transform basic discoveries into new treatments. CUMC was one of 12 medical centers to receive the first of these highly competitive NIH grants. By 2012, the NIH expects to have 60 centers across the country.